Company Filing History:
Years Active: 2016
Title: Laure Moutouh-De Parseval: Innovator in Pharmaceutical Combinations
Introduction
Laure Moutouh-De Parseval is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug combinations for treating proliferative diseases. Her work exemplifies the intersection of science and medicine, showcasing the potential of targeted therapies.
Latest Patents
Laure holds 1 patent for her invention titled "Pharmaceutical combinations comprising a B-RAF inhibitor, and EGFR inhibitor and optionally a PI3K-α inhibitor." This patent describes a pharmaceutical combination that includes a B-Raf inhibitor, an EGFR inhibitor, and optionally a PI3K inhibitor. The invention focuses on the uses of this combination in treating proliferative diseases and outlines methods for administering a therapeutically effective amount of the combination to patients suffering from such conditions.
Career Highlights
Laure Moutouh-De Parseval is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies. Her expertise in pharmaceutical sciences has positioned her as a key figure in her field.
Collaborations
Throughout her career, Laure has collaborated with notable colleagues, including Giordano Caponigro and Darrin Stuart. These collaborations have fostered a dynamic exchange of ideas and have contributed to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Laure Moutouh-De Parseval's contributions to the field of pharmaceuticals highlight her dedication to improving treatment options for patients with proliferative diseases. Her innovative work continues to inspire advancements in medical science and showcases the importance of collaboration in achieving significant breakthroughs.